From the State Key Laboratory of Cardiovascular Disease (J.L., Y.Z., J.W.), MR Center (S.Z., S.Y., L.L., J.S.), Cardiomyopathy Ward (G.W., D.W., L.K., L.S.), and National Clinical Research Center for Cardiovascular Diseases (L.S.), Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 167, Beilishilu, Xicheng District, 100037 Beijing, China.
Radiology. 2022 Feb;302(2):298-306. doi: 10.1148/radiol.2021210914. Epub 2021 Nov 2.
Background Myocardial replacement fibrosis is one of the major histologic features of hypertrophic cardiomyopathy (HCM), but its characteristics have not been well delineated. Purpose To clarify the characteristics of replacement fibrosis in HCM and to evaluate the prognostic value of the regional extent of fibrosis. Materials and Methods This prospective study evaluated participants with HCM who underwent contrast-enhanced cardiac MRI from March 2011 to April 2019. For each participant, global and 16-segment extent of late gadolinium enhancement (LGE) in the left ventricle (LV) at cardiac MRI was analyzed. The primary end point was all-cause death. Results Among the 798 study participants enrolled (median age, 49 years [interquartile range {IQR}: 38-59 years]; 508 men), 588 (74%) underwent whole-exome sequencing. Thirty-five participants (4%) experienced death from any cause during a median follow-up of 2.9 years (IQR: 1.5-4.7 years). Spearman analysis showed weak correlations between the extent of LGE and wall thickness (LGE of global LV and maximal LV wall thickness, = 0.35 [ < .001]; LGE and thickness of septum, = 0.30 [ < .001]). In the 16-segment model, the distribution of LGE was visually inhomogeneous and higher in the basal anterior, basal septal, midanterior, and midseptal regions ( < .001). This similar distribution of LGE was observed in participants with asymmetric septal hypertrophy, those with apical HCM, participants positive for mutation and those negative for mutation, and participants with and mutations. Cox analysis indicated that both the global extent of LGE (adjusted hazard ratio = 1.68 per 10% increase in LGE; < .001) and the regional extent of LGE (ie, basal, midventricular, and apical regions of LV when on the short-axis view; septum, anterior free wall, inferior free wall, and lateral free wall when on the long-axis view) were associated with adverse outcomes. Conclusion In hypertrophic cardiomyopathy, myocardial replacement fibrosis weakly correlated with hypertrophy, was inhomogeneous and asymmetric, and was predominantly distributed in the interventricular septal wall and anterior free wall at the basal and mid levels. Greater extent of fibrosis was associated with poor prognosis, regardless of its location in the left ventricle. © RSNA, 2021 See also the editorial by Hanneman in this issue.
背景 心肌替代纤维化是肥厚型心肌病(HCM)的主要组织学特征之一,但尚未明确其特征。目的 阐明 HCM 中替代纤维化的特征,并评估纤维化区域程度的预后价值。材料与方法 本前瞻性研究纳入了 2011 年 3 月至 2019 年 4 月期间接受对比增强心脏 MRI 的 HCM 患者。对每位患者的左心室(LV)心脏 MRI 的全局和 16 节段的延迟钆增强(LGE)程度进行分析。主要终点是全因死亡。结果 在纳入的 798 名研究参与者中(中位年龄 49 岁[四分位距{IQR}:38-59 岁];508 名男性),588 名(74%)进行了全外显子组测序。在中位随访 2.9 年(IQR:1.5-4.7 年)期间,35 名参与者(4%)因任何原因死亡。Spearman 分析显示,LGE 程度与壁厚度之间存在弱相关性(LV 全局 LGE 与最大 LV 壁厚度, = 0.35 [ <.001];LGE 与间隔厚度, = 0.30 [ <.001])。在 16 节段模型中,LGE 的分布不均匀,在前基底、基底间隔、中前和中隔区域较高( <.001)。在非对称性间隔肥厚、心尖 HCM、突变阳性和突变阴性、 和 突变参与者中观察到相似的 LGE 分布。Cox 分析表明,LV 全局 LGE 程度(调整后的危险比=每增加 10% LGE 增加 1.68; <.001)和局部 LGE 程度(即短轴视图时的 LV 基底、中隔和心尖区域;长轴视图时的间隔、前游离壁、下游离壁和侧游离壁)与不良预后相关。结论 在肥厚型心肌病中,心肌替代纤维化与肥厚程度弱相关,呈不均匀和不对称分布,主要分布在室间隔壁和前游离壁的基底和中层。纤维化程度越大,预后越差,而与纤维化在左心室的位置无关。©RSNA,2021 本期也可见 Hanneman 的社论。